SO
VRDN icon

STRS Ohio’s Viridian Therapeutics VRDN Stock Holding History

STRS Ohio’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$417K Buy
+21,300
New +$633K ﹤0.01% 1180
2023
Q2 		– Sell
-800
Closed -$20K – 2112
2023
Q1 		$20K Buy
+800
New +$25.7K ﹤0.01% 1867
2018
Q2 		– Sell
-247
Closed -$25K – 2184
2018
Q1 		$25K Hold
247
– – ﹤0.01% 1806
2017
Q4 		$38K Hold
247
– – ﹤0.01% 1780
2017
Q3 		$33K Hold
247
– – ﹤0.01% 1838
2017
Q2 		$47K Buy
+247
New +$41.7K ﹤0.01% 1802

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return